Delivery Order SPE2DB24D3013-SPE2DB25FFLKS
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,367.85, is for the delivery of letrozole 2.5mg medication tablets. It is a firm fixed-price, non-set-aside contract with a performance period extending through May 1, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,294.41, is for the delivery of Letrozole 2.5 mg tablets. The contract has a completion date of August 17, 2023 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count packages of the prescription drug Letrozole 2.5 mg tablets, with a total ceiling value of $4,736.41 and a performance period ending on April 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,800.88, is for the delivery of Letrozole 2.5 mg tablets in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,688.02 firm fixed-price delivery order is for the supply of 90-tablet bottles of the drug Letrozole 2.5 mg. The contract has a ceiling value of $9,688.02 and an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the medication Letrozole 2.5 mg tablets. The contract has a firm fixed-price, with a ceiling value of $1,237.59, and an ultimate completion date of November 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Letrozole 2.5 mg tablets, with a ceiling value of $2,774.22 and a period of performance running through February 18, 2025. The contract is a firm-fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $2,351.16, is for the supply of 90-count bottles of the prescription drug Letrozole 2.5 mg tablets. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.56 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Letrozole 2.5 mg. The contract has a completion date of March 13, 2025 and was awarded on March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Letrozole 2.5 mg tablets. The $1,075.22 contract has a completion date of February 14, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor for this order, which is issued under a larger indefinite delivery contract with DLA Troop Support Medical, valued at up to...